Form 4 for GEHC GE HealthCare
Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-05 · accession 0001628280-24-045277 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-05 | 2024-11-05 | GEHC | Rackliffe Philip | CEO, AVS | S - Sale | $87.63 | -900 | 12.7K | -7% | -$78.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2024-11-05 | S | D | 900 | $87.63 | 12,715 | D | — | — | (F1) The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $87.63 to $87.66, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). |